首页> 外国专利> S6K2 BLOCKADE PERTURBS REDOX BALANCE AND FATTY ACID METABOLISM, LEADING TO OXIDATIVE CELL DEATH IN MAPK INHIBITOR RESISTANT CANCERS

S6K2 BLOCKADE PERTURBS REDOX BALANCE AND FATTY ACID METABOLISM, LEADING TO OXIDATIVE CELL DEATH IN MAPK INHIBITOR RESISTANT CANCERS

机译:S6K2阻滞干扰氧化还原平衡和脂肪酸代谢,导致抗MAPK抑制剂的氧化性细胞死亡。

摘要

NRAS Mutant melanoma cells involve certain pathways for induction of ferroptosis. Accordingly, our studies indicate that cancers with MAPK inhibitors will also be susceptible to treatment with the ferroptosis inducing agents. In a particular example, RAS mutant cancers, such as pancreas, lung, colon and thyroid, as non-limiting examples, would be susceptible to treatment with a ferroptosis/lipid peroxidation inducing agent as provided for in the examples, data, and methods as described herein.
机译:NRAS突变性黑素瘤细胞涉及某些诱导铁褐变的途径。因此,我们的研究表明,具有MAPK抑制剂的癌症也容易受铁锈病诱导剂的治疗。在一个特定的实例中,作为非限制性实例的RAS突变癌,例如胰腺,肺癌,结肠癌和甲状腺癌,将易于接受如实施例,数据和方法中所提供的肥大病/脂质过氧化诱导剂的治疗。本文所述。

著录项

  • 公开/公告号WO2019200343A1

    专利类型

  • 公开/公告日2019-10-17

    原文格式PDF

  • 申请/专利权人 THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY;

    申请/专利号WO2019US27367

  • 发明设计人 VILLANUEVA JESSIE;

    申请日2019-04-12

  • 分类号A61P35;C12Q1;C12Q1/68;

  • 国家 WO

  • 入库时间 2022-08-21 11:52:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号